# Prognostic Value of Myocardial Fibrosis Quantified Using CMR in Patient With Dilated Cardiomyopathy

> **NCT02352129** · NA · COMPLETED · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 262 (actual)

## Conditions studied

- Cardiomyopathy, Dilated

## Interventions

- **OTHER:** CMR using T1 mapping technique

## Key facts

- **NCT ID:** NCT02352129
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2017-01
- **Final completion:** 2017-06
- **Target enrollment:** 262 (ACTUAL)
- **Last updated:** 2026-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02352129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02352129, "Prognostic Value of Myocardial Fibrosis Quantified Using CMR in Patient With Dilated Cardiomyopathy". Retrieved via AI Analytics 2026-07-23 from https://api.ai-analytics.org/clinical/NCT02352129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*